临床试验

A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation

NCT：NCT07073950 · RECRUITING

NCT编号NCT07073950

状态RECRUITING

开始日期2025-11-24

完成时间2027-05-31

SponsorAstraZeneca (INDUSTRY)

First posted2025-07-20

Last updated2026-09-18

简要摘要

The purpose of the study is to evaluate the effect of BGF MDI compared with placebo MDI on cardiac and lung function when administered in participants diagnosed with COPD and hyperinflation.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。